Filing Flows › Health Care › Adia Med (ADIA)
Adia Med (ADIA) earnings and revenue breakdown
Latest: Q2 2026 · 10-Q filed Aug 13, 2026 · Adia Med (ADIA) Q2 2026 earnings results →
Q2 2026 Revenue up 311% year over year to $485K · 8¢ of every $1 of revenue kept as net profit · operating margin 10.7%
Adia Med made $485K in Q2 2026 (+311% Y/Y): Medical Procedures $330K, Sales of Biologics $152K, Shipping and Delivery $4K. Operating margin 10.7%, net earnings $40K. See where every dollar goes — costs, profit and cash — as a Sankey from the 10-Q filed Aug 13, 2026.
Drawing the Sankey…
Open the interactive Sankey → click any line for what the company wrote about it, compare Y/Y and Q/Q, export as PNG or PDF
What changed this quarter
Revenue was $485K in Q2 2026, up 311% year over year and up 175% from the previous quarter. Medical Procedures was the largest line at 68% of revenue. Medical Procedures added $304K year over year (up 1169%), 83% of the total change.
Gross margin was 58.2%, up 36.3 points from a year earlier. Operating profit was $52K, a 10.7% margin (up 109.4 points year over year). Operating expenses grew 62% against revenue growth of 311%. Net earnings were $40K. The effective tax rate was 0.0%.
Operating cash flow was −$109K. Non-cash charges added back $1K of depreciation. Working capital and other items used $151K. Capital expenditures of $0K exceeded it, leaving free cash flow of −$109K.
Quarterly history
| Quarter | Form | Filed | Revenue | Y/Y | Op. margin | Net earnings | Op. cash flow |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 10-Q | Aug 13, 2026 | $485K | +311% | 10.7% | $40K | −$109K |
| Q1 2026 | 10-Q | May 15, 2026 | $176K | +146% | -86.2% | −$163K | −$55K |
Charts
Interactive views
The same charts as the app — open one to draw it.
💵Where each $1 goesinteractive
Loading the interactive chart…
🌏Named in Asian annual reportsinteractive
Loading the interactive chart…
🔄Rotation against the market and its industry (RRG)interactive
Loading the interactive chart…
🔍Earnings qualityinteractive
Loading the interactive chart…
⚖️Fair value by methodinteractive
Loading the interactive chart…
🔭Outlook & guidanceinteractive
Loading the interactive chart…
📈Investments: gains and what it boughtinteractive
Loading the interactive chart…
🏭Its industry’s money flow (input-output)interactive
Loading the interactive chart…
About Adia Med
ADIA Nutrition Inc. (the “Corporation”), a corporation incorporated under the laws of the State of Nevada on April 24, 1975, as Domi Associates, Inc. Subsequently, the Company amended its articles of incorporation in March 2001, changing its name to Drilling, Inc., and again changed its name to PIVX Solutions, Inc in April 2004. The Company amended its articles of incorporation in 2012 to change its name to the current name of ADIA Nutrition, Inc. The Company had abandoned its business and failed to take steps to dissolve, liquidate and distribute its assets. It had also failed to meet the required reporting requirements with the Nevada Secretary of State, hold an annual meeting of stockholders and pay its annual franchise tax from 2013 to 2022 which resulted in its Nevada charter being revoked.
In its own words, from its 10-K, filed Mar 31, 2026.
Adia Med against its Medicinal Chemicals & Botanical Products peers
The largest companies of the same SEC industry, each at its latest quarter. Revenue growth: +311% against the peers' median +11%. Operating margin: 10.7% against the peers' median 4.2%.
| Company | Quarter | Revenue | Y/Y | Op. margin |
|---|---|---|---|---|
| ADIA Adia Med | Q2 2026 | $485K | +311% | 10.7% |
| CURLF Curaleaf Holdings | Q3 2026 | $353M | +11% | 0.8% |
| TLRY Tilray Brands | Q1 FY27 | $257M | +23% | -9.4% |
| TRLV Trulieve Cannabis | Q3 2026 | $230M | -20% | 18.5% |
| USNA Usana Health Sciences | Q2 2026 | $223M | -5% | -9.0% |
| AAWH Ascend Wellness Holdings | Q2 2026 | $126M | -0.9% | 4.2% |
| CRON Cronos Group | Q3 2026 | $83.9M | +72% | 10.8% |
| CGC Canopy Growth | Q2 FY27 | $71.1M | +20% | -23.1% |
| JUSH Jushi Holdings | Q3 2026 | $70.5M | +7% | 5.0% |
Source: Adia Med 10-Q on SEC EDGAR · CIK 1160420 · Medicinal Chemicals & Botanical Products
More on ADIA
History
Every quarter: Q2 2026 results · Q1 2026 results